Published • loading... • Updated
Prix Galien International 2026, Daiichi Sankyo and AstraZeneca Win the Award for the Best Biotechnology Product
Summary by Fortune Italia
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The Prix Galien International 2026 was awarded to Daiichi Sankyo and AstraZeneca in the category dedicated to the best biotechnological product for trastuzumab deruxtecan (T-DXd). T-DXd belongs to the class of drug-married antibodies (ADC), a new generation of cancer medicines that combine a monoclonal antibody with a chemotherapy substance. The antibody recognizes the HER2 receptor, present on [...] L'articolo Prix Galien International 2026, Da…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
